Ivy Foundation Translational Adult Glioma Grant Award 2024

Ivy Foundation
Application Due Date
Brief Description

Program Description

The Ben & Catherine Ivy Foundation Emerging Adult Glioma Award provides grant support to investigators conducting high-impact, high-reward translational research for glioblastoma.  This award is intended to support projects designed to contribute to identifying therapies that will impact the survival of patients with brain cancer.


  • A PhD, MD or equivalent is required.
  • Only one submission per applicant is permitted every calendar year.
  • Applicants need not be U.S. citizens, but must be employed by a U.S. non-profit academic institution.
  • The Ben & Catherine Ivy Foundation does not discriminate on the basis of race, color, religion, national origin, sex, gender identity, sexual orientation, age, disability or any other legally protected characteristics.
  • Clinical trials eligible

Award Terms

  • $600,000 total, payments received at initiation and completion of project
  • Project duration is 24 months
  • The proposal milestones are to be completed within the two year award timeline
  • Indirect costs not to exceed 10% (included in award total-$60,000 maximum)
  • One Principal Investigator allowed; Co-Investigators permitted
  • No Cost Extensions are not permitted by contract

Key Dates

  • March 1, 2024, ( By midnight on this Date): Application Due (Please do not send before January 1, 2024)
  • May 1, 2024: Selection of Awardees
  • June 15, 2024: Signed Agreements Due
  • July 1, 2024: Award Start Date